FDA Clearance of PrimeraDx ICEPlex, C. Diff Assay Opens Doors for Additional Tests | GenomeWeb

PrimeraDx said this week that the US Food and Drug Administration has granted 510(k) clearance for its ICEPlex C. difficile assay kit and ICEPlex molecular diagnostics system.

The approval provides PrimeraDx with a runway from which to commercially launch a number of additional multi-analyte in vitro diagnostics in infectious disease and oncology, including companion diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.